Fighting Infectious Diseases in Emerging Countries

Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial

Edwin J. Asturias, Ananda S Bandyopadhyay, Steve Self et al. · The Lancet · 2016 · 83 citations · Full text

Life Sciences, Immunology, Pediatrics +17

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials

Xavier Sáez‐Llorens, Ananda S Bandyopadhyay, Christopher Gast et al. · The Lancet · 2020 · 77 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study

Miguel O’Ryan, Ananda S Bandyopadhyay, Rodolfo Villena et al. · The Lancet Infectious Diseases · 2015 · 77 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants

Peter F. Wright, Ruth I. Connor, Wendy Wieland‐Alter et al. · The Lancet Infectious Diseases · 2016 · 64 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial

Ananda S Bandyopadhyay, Chris Gast, Luis Rivera et al. · The Lancet Infectious Diseases · 2020 · 31 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17